Sobi - Swedish Orphan Biovitrum AB (publ) · 1 day ago
Sr. Director, Immunology Strategy
Sobi is a specialized biopharmaceutical company dedicated to rare diseases. The Sr. Director of Immunology Strategy will advance the immunology commercial strategy, drive sales effectiveness, and support leadership on strategic initiatives, collaborating with cross-functional teams to ensure the success of immunology brands and upcoming launches.
BiotechnologyGeneticsMedicalPharmaceutical
Responsibilities
Support the development and execution of immunology commercial strategy, focusing on ensuring the right priorities and building the necessary capabilities to enable
Support our launch teams with strategic guidance and drive ad hoc, critical initiatives that enhance our launches in Immunology
Define Immunology portfolio priorities with Marketing, Sales, Medical, Access, and Finance
Manage and execute ad hoc projects that align with the strategic goals of the immunology franchise
Support opportunity assessments for new disease areas and other life cycle management initiatives, providing insights and recommendations
Work with Sales, Market Access, Commercial Insights & Operations, Marketing, and other cross-functional leads to develop and execute high priority initiatives
Provide strategic and operational support to the sales team, ensuring alignment with immunology objectives
Provide support and strategic input into how we track performance, opportunities, and the impact of activities
Support targeting and alignments for commercial field roles, ensuring effective deployment of resources
Manage Immunology Leadership Team (LT) meetings with agenda setting preparation of materials, facilitation of the meetings, and follow-up activities
In partnership with other leaders, manage key team meetings (e.g., quarterly Immunology Town Halls, annual POAs)
Foster clear communication and coordination among various field roles and cross-functional teams to maximize impact and minimize confusion
Play a key role in evolving the culture within the immunology franchise, fostering collaboration and innovation
Lead development approach to enhance our Sobi Immunology presence and attract talent
Support initiatives (field collateral and digital engagement) to enhance Sobi's perception and awareness in Immunology across professional associations, key customers, and in coordination with advocacy and policy partner
Lead or support cross-functional PMOs focused on launch preparation and other business transitions, as needed, to ensure seamless operations, change management and value creation
Qualification
Required
Bachelor's degree in a relevant field
10+ years working with/in Biopharma with a mix of direct Biopharma and top-tier consulting experience
Mix of strategy (corporate/brand/portfolio) and operational experience with significant U.S. market exposure
Launch and lifecycle experience in specialty/rare disease settings
Excellent communication and leadership skills, with experience in cross-functional collaboration and leadership
Strong analytical skills with the ability to develop clear insights and recommendations
Ability to manage and prioritize multiple projects and initiatives simultaneously, with a focus on achieving strategic goals
Highly developed organizational agility and 'can do' approach
Experience working closely with executive management in various work situations
Proficiency with PowerPoint, Microsoft Excel, AI Chat (e.g., ChatGPT, Gemini) and other reporting and tracking tools (e.g. Veeva CRM and Tableau)
Ability to travel up to 30%
Preferred
Advanced degree (MBA or medical) preferred
Benefits
A competitive 401(k) match to support your financial future.
Tuition and wellness reimbursements to invest in your personal and professional growth.
A comprehensive medical, dental, and vision package to prioritize your health and well-being.
Additional recognition awards to celebrate your achievements.
Company
Sobi - Swedish Orphan Biovitrum AB (publ)
Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases.
Funding
Current Stage
Public CompanyTotal Funding
$825.99M2024-05-08Post Ipo Debt· $274.92M
2023-08-22Post Ipo Equity· $551.07M
2006-09-15IPO
Leadership Team
Guido Oelkers
Chief Executive Officer
Recent News
Pharma Letter
2025-12-16
Company data provided by crunchbase